Showing results (31-40 of 97) with videos related to
Sort By:
Pageof 10
Anticancer Research|April 22, 2011
Polymorphisms of the CYP1A1, CYP2E1 and XRCC1 genes and cancer risk in a Southern Italian population: a case-control studyGabriella Bianchino, Achille Cittadini, Vitina Grieco, et al.Future Oncology (London, England)|April 24, 2014
Long-term survival in small cell lung cancer: a case report and review of the literatureAlfredo Tartarone, Rosa Lerose, Raffaele Ardito, et al.Advances in Anatomic Pathology|April 10, 2014
Selected case from the Arkadi M. Rywlin International Pathology Slide Series: Leiomyomatosis peritonealis disseminata: report of 3 cases with extensive review of the literatureMichele Bisceglia, Carlos A Galliani, Stefano Pizzolitto, et al.American Journal of Clinical Oncology|December 15, 2004
Weekly gemcitabine, paclitaxel, oxaliplatin combination chemotherapy in patients with Cisplatin-refractory germ cell tumor: preliminary experienceUgo De Giorgi, Giovanni Rosti, Giorgio Papiani, et al.Investigational New Drugs|January 29, 2019
The influence of prior ramucirumab treatment on the clinical activity of FOLFIRI as third-line therapy in patients with metastatic gastric CancerGiandomenico Roviello, Roberto Petrioli, Pietro Rosellini, et al.Journal of Thoracic Disease|November 30, 2017
Liquid biopsy for monitoring anaplastic lymphoma kinase inhibitors in non-small cell lung cancer: two cases comparedMariangela Manicone, Maria Chiara Scaini, Maria Grazia Rodriquenz, et al.Future Oncology (London, England)|March 14, 2012
Anal metastasis from breast cancer: a case report and review of the literatureAnnamaria Bochicchio, Alfredo Tartarone, Orazio Ignomirelli, et al.Lung Cancer (Amsterdam, Netherlands)|July 2, 2013
Mechanisms of resistance to EGFR tyrosine kinase inhibitors gefitinib/erlotinib and to ALK inhibitor crizotinibAlfredo Tartarone, Chiara Lazzari, Rosa Lerose, et al.Expert Opinion on Biological Therapy|December 16, 2014
The epidermal growth factor receptors as biological targets in penile cancerGiuseppe Di Lorenzo, Carlo Buonerba, Matteo Ferro, et al.Medical Oncology (Northwood, London, England)|February 2, 2018
Uncommon frame-shift exon 19 EGFR mutations are sensitive to EGFR tyrosine kinase inhibitors in non-small cell lung carcinomaGiuseppina Improta, Angela Zupa, Maria Iole Natalicchio, et al.Pageof 10